Involvement of oxidative stress in atherosclerosis development in subjects with sarcopenic obesity

R Nakano, N Takebe, M Ono, M Hangai, R Nakagawa, S Yashiro, T Murai, K Nagasawa, Y Takahashi, J Satoh, Y Ishigaki, R Nakano, N Takebe, M Ono, M Hangai, R Nakagawa, S Yashiro, T Murai, K Nagasawa, Y Takahashi, J Satoh, Y Ishigaki

Abstract

Keywords: Atherosclerosis; obesity; oxidative stress; sarcopenia.

Figures

Figure 1
Figure 1
Box plot of maximum intima‐media thickness (a) and urinary 8‐isoprostane (b). TPA, total psoas area.

References

    1. Riechman SE, Schoen RE, Weissfeld JL, Thaete FL, Kriska AM. Association of physical activity and visceral adipose tissue in older women and men. Obesity Research 2002; 10: 1065–1073.
    1. Kim TN, Park MS, Yang SJ, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 2010; 33: 1497–1499.
    1. Hasselager R, Gogenur I. Core muscle size assessed by perioperative abdominal CT scan is related to mortality, postoperative complications, and hospitalization after major abdominal surgery: a systematic review. Langenbeck's Archives of Surgery 2014; 399: 287–295.
    1. Shen W, Punyanitya M, Wang Z, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross‐sectional image. Journal of Applied Physiology (1985) 2004; 97: 2333–2338.
    1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet (London, England). 2005; 365: 1415–1428.
    1. Funatogawa I, Funatogawa T, Nakao M, Karita K, Yano E. Changes in body mass index by birth cohort in Japanese adults: results from the National Nutrition Survey of Japan 1956–2005. International Journal of Epidemiology 2009; 38: 83–92.
    1. Tanaka S, Horimai C, Katsukawa F. Ethnic differences in abdominal visceral fat accumulation between Japanese, African‐Americans, and Caucasians: a meta‐analysis. Acta Diabetologica 2003; 40: S302–S304.
    1. Mandavilli A, Cyranoski D. Asia's big problem. Nature Medicine 2004; 10: 325–327.
    1. Lim S, Kim JH, Yoon JW, et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 2010; 33: 1652–1654.
    1. Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity: a new category of obesity in the elderly. Nutrition, Metabolism, and Cardiovascular Diseases 2008; 18: 388–395.
    1. Sanada K, Iemitsu M, Tabata I, et al. A cross‐sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors and metabolic syndrome. Nihon Ronen Igakkai Zasshi 2012; 49: 715–717.
    1. Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population‐based cohort study of older men. Journal of the American Geriatrics Society 2014; 62: 253–260.
    1. Batsis JA, Mackenzie TA, Barre LK, Lopez‐Jimenez F, Bartels SJ. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. European Journal of Clinical Nutrition 2014; 68: 1001–1007.
    1. Stephen WC, Janssen I. Sarcopenic‐obesity and cardiovascular disease risk in the elderly. The Journal of Nutrition, Health & Aging 2009; 13: 460–466.
    1. Aubertin‐Leheudre M, Lord C, Goulet ED, Khalil A, Dionne IJ. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity (Silver Spring). 2006; 14: 2277–2283.
    1. Sakuma K, Yamaguchi A. Sarcopenic obesity and endocrinal adaptation with age. International Journal of Endocrinology 2013; 2013: 204164.
    1. Jones KI, Doleman B, Scott S, Lund JN, Williams JP. Simple psoas cross‐sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications. Colorectal Disease 2015; 17: O20–O26.
    1. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VEA. practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Applied Physiology, Nutrition, and Metabolism 2008; 33: 997–1006.
    1. Peng PD, van Vledder MG, Tsai S, et al. Sarcopenia negatively impacts short‐term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford). 2011; 13: 439–446.
    1. Ono M, Takebe N, Oda T, et al. Association of coronary artery calcification with MDA‐LDL‐C/LDL‐C and urinary 8‐isoprostane in Japanese patients with type 2 diabetes. Internal Medicine 2014; 53: 391–396.
    1. Morse WI, Soeldner JS. The non‐adipose body mass of obese women: evidence of increased muscularity. Canadian Medical Association Journal 1964; 90: 723–725.
    1. Ochi M, Kohara K, Tabara Y, et al. Arterial stiffness is associated with low thigh muscle mass in middle‐aged to elderly men. Atherosclerosis 2010; 212: 327–332.
    1. Park SW, Goodpaster BH, Strotmeyer ES, et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes 2006; 55: 1813–1818.
    1. Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity‐associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PloS One 2010; 5: e10805.
    1. Kato A, Ishida J, Endo Y, et al. Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients. Nephrology, Dialysis, Transplantation 2011; 26: 1967–1976.
    1. Kohara K, Ochi M, Tabara Y, Nagai T, Igase M, Miki T. Arterial stiffness in sarcopenic visceral obesity in the elderly: J‐SHIPP study. International Journal of Cardiology 2012; 158: 146–148.
    1. Kim TN, Choi KM. The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease. Journal of Cellular Biochemistry 2015; 116: 1171–1178.
    1. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nature Reviews. Endocrinology 2012; 8: 457–465.
    1. Vincent HK, Raiser SN, Vincent KR. The aging musculoskeletal system and obesity‐related considerations with exercise. Ageing Research Reviews 2012; 11: 361–373.
    1. Ishigaki Y, Katagiri H, Gao J, et al. Impact of plasma oxidized low‐density lipoprotein removal on atherosclerosis. Circulation 2008; 118: 75–83.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren